EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseStudienprotokollOpen Access · CC BY 4.0

Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trials

Brian Mac Grory iD, Cécile Preterre, Pierre Lebranchu, Stephen James Ryan iD, Øystein Kalsnes Jørstad iD, Morten Carstens Moe, Johannes Tünnerhoff iD, Martin S Spitzer iD, Carsten Grohmann, Oana M Dumitrascu, Valérie Biousse, Benoit Guillon und 4 weitere

PLOS One · 10.03.2026 · 21 (3) · e0342739

DOI: 10.1371/journal.pone.0342739 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 10.03.2026. Verfasst von Brian Mac Grory und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology, Duke University School of Medicine, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Retinal Artery Occlusion, Thrombolytic Therapy, Fibrinolytic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Central retinal artery occlusion (CRAO) is a disabling subtype of acute ischemic stroke. It is not known whether intravenous (IV) thrombolysis delivered within 4.5 hours of time last known well (LKW) improves visual outcomes. Study design Systematic review and individual participant data meta-analysis. Objective The objective of this study is to determine whether IV thrombolysis improves visual outcomes among patients with acute non-arteritic CRAO when administered within 4.5 hours of time LKW compared with placebo, no IV thrombolysis, and/or anti-thrombotic therapy. Evidence review plan This study is prospectively registered through PROSPERO (#1154900). We will include randomized controlled trials (RCTs) that enroll patients with non-arteritic CRAO presenting within 4.5 hours of time LKW. We will not include non-controlled interventional studies or retrospective studies. We will search MEDLINE, Embase, the Cochrane Library, Web of Science, and the ClinicalTrials.gov registry from inception through the date of commencement of the systematic review. We will assess the risk of bias using the Cochrane Risk of Bias Tool 2.0. We will contact the corresponding author(s) of any studies identified that meet the study selection criteria. We will inspect, harmonize, and collate trial datasets. The primary end point will be attainment of a final best corrected visual acuity (BCVA) equal to or better than 20/63 (logarithm of the minimum angle of resolution [logMAR] of ≤0.5). Secondary end points will include shift analyses of key visual acuity outcome categories according to the World Health Organization (WHO) International Classification of Disease (ICD)-11, final BCVA considered as a continuous variable, final BCVA equal to or better than 20/100 (logMAR of ≤0.7), final BCVA equal to or better than 20/200 (logMAR of ≤1), a quantitative measure of visual field function (where available), global disability (modified Rankin Scale score [mRS]), and key safety end points (including symptomatic intracranial hemorrhage [sICH] and other systemic hemorrhage). We will fit a series of mixed logistic and linear regression models with trial, and trial by treatment interaction terms as random effects. To probe for sources of heterogeneity, we will pursue a series of subgroup and sensitivity analyses. Finally, a GRADE assessment will be presented. Conclusions and relevance Completion of the proposed study will permit a synopsis of the interventional literature on IV thrombolysis for CRAO, generate a pooled estimate of the treatment effect, and allow exploration of sources of heterogeneity. Such results may be of interest to healthcare professionals, guideline development bodies, policymakers, payors, and future patients with CRAO. Registration This systematic review is prospectively registered: PROSPERO #1154900.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Artery OcclusionThrombolytic TherapyFibrinolytic AgentsHumansSystematic Reviews as TopicRandomized Controlled Trials as TopicMeta-Analysis as TopicAdministration, IntravenousTreatment Outcome

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Departments of Neurology, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Duke Clinical Research Institute, Durham, North Carolina, United States of America.
  • ORBIT Interdisciplinary Hub, Duke University, Durham, North Carolina, United States of America.
  • Departments of Neurology and Ophthalmology, CHU de Nantes - Laennec Nantes, France.
  • Department of Neurology, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Brian Mac Grory, Stephen James Ryan, Øystein Kalsnes Jørstad, Johannes Tünnerhoff, Martin S Spitzer, Sven Poli, Matthew Schrag

Zitieren

APA

Mac Grory, B., Preterre, C., Lebranchu, P., Ryan, S. J., Kalsnes Jørstad, Ø., Moe, M. C., Tünnerhoff, J., Spitzer, M. S., Grohmann, C., Dumitrascu, O. M., Biousse, V., Guillon, B., Aamodt, A. H., Poli, S., Schrag, M., & Central Retinal ArterY OcclusioN (CRAYON) Collaborators (2026). Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trials. PLOS One, 21(3), e0342739. https://doi.org/10.1371/journal.pone.0342739

Vancouver

Mac Grory B, Preterre C, Lebranchu P, Ryan SJ, Kalsnes Jørstad Ø, Moe MC, et al. Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trials. PLOS One. 2026;21(3):e0342739. doi:10.1371/journal.pone.0342739

BibTeX
@article{MacGrory2026,
  author = {Mac Grory, Brian and Preterre, Cécile and Lebranchu, Pierre and Ryan, Stephen James and Kalsnes Jørstad, Øystein and Moe, Morten Carstens and Tünnerhoff, Johannes and Spitzer, Martin S and Grohmann, Carsten and Dumitrascu, Oana M and Biousse, Valérie and Guillon, Benoit and Aamodt, Anne Hege and Poli, Sven and Schrag, Matthew and Central Retinal ArterY OcclusioN (CRAYON) Collaborators, Central Retinal ArterY OcclusioN (CRAYON) Collaborators},
  title = {Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trials},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0342739},
  doi = {10.1371/journal.pone.0342739}
}
Kostenlos starten →